{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:39:46Z","timestamp":1791175186707,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.atherosclerosis.2013.08.030","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T01:17:08Z","timestamp":1378257428000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins"],"prefix":"10.1016","volume":"231","author":[{"given":"Masashi","family":"Shiomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2012.07.007","article-title":"The controversies of statin therapy: weighing the evidence","volume":"60","author":"Jukema","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2009.03.024","article-title":"The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe","volume":"207","author":"Shiomi","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib3","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.7164\/antibiotics.29.1346","article-title":"ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by penicillium citrinum","volume":"29","author":"Endo","year":"1976","journal-title":"J\u00a0Antibiot (Tokyo)"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib4","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1016\/S0021-9258(19)42341-7","article-title":"Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia","volume":"249","author":"Goldstein","year":"1974","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0021-9150(80)90234-8","article-title":"Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit)","volume":"36","author":"Watanabe","year":"1980","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0014-5793(80)81223-3","article-title":"WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia","volume":"118","author":"Tanzawa","year":"1980","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib7","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1073\/pnas.78.4.2268","article-title":"Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia","volume":"78","author":"Kita","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib8","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1126\/science.3010466","article-title":"Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit","volume":"232","author":"Yamamoto","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/hum.1996.7.8-943","article-title":"Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits","volume":"7","author":"Kozarsky","year":"1996","journal-title":"Hum Gene Ther"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2013.08.030_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.ATV.6.3.345","article-title":"Increased lipid transfer activities in hyperlipidemic rabbit plasma","volume":"6","author":"Son","year":"1986","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0021-9150(98)00259-7","article-title":"Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows synergistic effect on atherosclerosis of WHHL rabbits","volume":"142","author":"Shiomi","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0021-9150(85)90085-1","article-title":"The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits, an animal model for familial hypercholesterolemia","volume":"56","author":"Watanabe","year":"1985","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0021-9150(92)90036-G","article-title":"Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis","volume":"96","author":"Shiomi","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/01.ATV.0000075947.28567.50","article-title":"Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit)","volume":"23","author":"Shiomi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0005-2760(79)90028-6","article-title":"Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals","volume":"575","author":"Endo","year":"1979","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib16","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0022-2275(20)41379-3","article-title":"The discovery and development of HMG-CoA reductase inhibitors","volume":"33","author":"Endo","year":"1992","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0005-2760(86)90117-7","article-title":"CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue selective inhibition of sterol synthesis and hypolipidemic effects on various animal species","volume":"877","author":"Tsujita","year":"1986","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib18","series-title":"Lipoproteins \u2013 role in health and diseases","first-page":"533","article-title":"Genetically modified animal models for lipoprotein research","author":"Shiomi","year":"2012"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib19","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1074\/jbc.270.22.13042","article-title":"Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside\/nucleotide deaminases","volume":"270","author":"Nakamuta","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib20","doi-asserted-by":"crossref","first-page":"10796","DOI":"10.1016\/S0021-9258(18)99088-5","article-title":"Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice","volume":"266","author":"Agellon","year":"1991","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib21","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI116663","article-title":"Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery","volume":"92","author":"Ishibashi","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib22","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1073\/pnas.95.8.4544","article-title":"Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a)","volume":"95","author":"Sanan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-2275(20)33334-4","article-title":"Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E","volume":"40","author":"Mahley","year":"1999","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0022-2275(20)37649-5","article-title":"Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48- relative to B-100-containing lipoproteins","volume":"37","author":"Li","year":"1966","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/01.ATV.2.6.467","article-title":"Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia","volume":"2","author":"Havel","year":"1982","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0021-9150(81)90100-3","article-title":"Hypolipidemic effects of CS-500 (ML-236B) in WHHL-Rabbit, a heritable animal model for hyperlipidemia","volume":"38","author":"Watanabe","year":"1981","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0026-0495(94)90196-1","article-title":"Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits","volume":"43","author":"Shiomi","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0005-2760(95)00155-6","article-title":"High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits","volume":"1259","author":"Kurokawa","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib29","first-page":"995","article-title":"Lipid lowering and antiatherosclerotic effect of NK 104, a potent 3-Hydroxy 3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits","volume":"50","author":"Suzuki","year":"2000","journal-title":"Arzneim Forsh\/Drug Res"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib30","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.CIR.79.5.1084","article-title":"Induction of mRNA for low-density lipoprotein receptor in heterozygous Watanabe heritable hyperlipidemic rabbits treated with CS-514 (Pravastatin) and cholestyramine","volume":"79","author":"Kume","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib31","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1073\/pnas.83.21.8370","article-title":"Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits","volume":"83","author":"Ma","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib32","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1073\/pnas.78.2.1194","article-title":"Regulatory role for hepatic low density lipoprotein receptors in\u00a0vivo in the dog","volume":"78","author":"Kovanen","year":"1981","journal-title":"Proc Natl Aced Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib33","first-page":"353","article-title":"Kinetic defects in the processing of the low density lipoprotein receptor in fibroblasts from WHHL rabbits and a family with familial hypercholesterolemia","volume":"1","author":"Schneider","year":"1983","journal-title":"Mol Biol Med"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1432-1033.1981.tb05555.x","article-title":"Biochemical characterization of skin fibroblasts derived from WHHL-rabbit, a notable animal model for familial hypercholesterolemia","volume":"118","author":"Shimada","year":"1981","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0031-6989(81)80063-X","article-title":"Influence of mevinolin on experimental atherosclerosis in rabbits","volume":"13","author":"Krichevsky","year":"1981","journal-title":"Pharmacol Res Commun"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)31679-5","article-title":"Mechanisms for cholesterol homeostasis in rat jejunal mucosa: effects of cholesterol, sitosterol, and lovastatin","volume":"42","author":"Nguyen","year":"2001","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0005-2760(88)90037-9","article-title":"Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits","volume":"960","author":"Watanabe","year":"1988","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib38","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1073\/pnas.84.16.5928","article-title":"Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia","volume":"84","author":"Kita","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib39","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1073\/pnas.84.21.7725","volume":"84","author":"Carew","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib40","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bjp.0702382","article-title":"Effects of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits","volume":"126","author":"Shiomi","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5551\/jat.10.109","article-title":"Plaque-stabilizing effect of pitavastatin in Watanabe heritable hyperlipidemic (WHHL) rabbits","volume":"10","author":"Suzuki","year":"2003","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000112634","article-title":"Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atheroscelrosis","volume":"36","author":"Worthley","year":"2007","journal-title":"Pathophysiol Haemaost Thromb"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0021-9150(90)90132-3","article-title":"Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine","volume":"83","author":"Shiomi","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib44","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/01.ATV.14.6.931","article-title":"Cell compositions of coronary and aortic atherosclerotic lesions in WHHL rabbits differ: an immunohistochemical study","volume":"14","author":"Shiomi","year":"1994","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib45","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.ATV.15.11.1938","article-title":"Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques: effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits","volume":"15","author":"Shiomi","year":"1995","journal-title":"Arterioscler Theromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2013.08.030_bib46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0021-9150(00)00708-5","article-title":"Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins","volume":"157","author":"Shiomi","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.atherosclerosis.2004.10.024","article-title":"Atheroma stabilizing effects of simvastatin due to depression of macrophages or lipid accumulation in the atheromatous plaques of coronary atherosclerosis-prone WHHL rabbits","volume":"178","author":"Shiomi","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.CIR.103.2.276","article-title":"An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in\u00a0vivo and in\u00a0vitro","volume":"103","author":"Aikawa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib49","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.CIR.103.7.993","article-title":"Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits","volume":"103","author":"Fukumoto","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib50","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/01.CIR.87.6.1781","article-title":"Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease","volume":"87","author":"Brown","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib51","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/01.CIR.91.10.2528","article-title":"Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)","volume":"91","author":"Jukema","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib52","first-page":"1845","article-title":"Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques","volume":"47","author":"Ogawa","year":"2006","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.atherosclerosis.2011.05.029","article-title":"Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide\/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits","volume":"218","author":"Iwata","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1172\/JCI0216421","article-title":"Isoprenoids as mediators of the biological effects of statins","volume":"110","author":"Liao","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib55","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","article-title":"Antiatherothrombotic properties of statins","volume":"279","author":"Rosenson","year":"1998","journal-title":"Jm Assoc Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0021-9150(93)90265-V","article-title":"The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits","volume":"103","author":"Kroon","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib57","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0735-1097(97)00537-8","article-title":"Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys","volume":"31","author":"Williams","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib58","doi-asserted-by":"crossref","first-page":"H2649","DOI":"10.1152\/ajpheart.2000.279.6.H2649","article-title":"Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs","volume":"279","author":"Mital","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yjmcc.2011.09.014","article-title":"Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?","volume":"52","author":"Balakumar","year":"2012","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib60","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.0000028465.52694.9B","article-title":"Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma","volume":"106","author":"Aikawa","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib61","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/01.CIR.97.24.2433","article-title":"Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization","volume":"97","author":"Aikawa","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib62","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/01.CIR.100.11.1215","article-title":"Dietary lipid lowering reduces tissue factor expression in rabbit atheroma","volume":"100","author":"Aikawa","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib63","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/0140-6736(93)90634-S","article-title":"Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients","volume":"341","author":"Leung","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib64","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/bjp.2008.143","article-title":"Lapaquistat acetate, a squalene synthesis inhibitor, changes macrophage\/lipid-rich coronary plaques of hypercholesterolemic rabbits into fibrous lesions","volume":"154","author":"Shiomi","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib65","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0005-2760(96)00184-1","article-title":"Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types","volume":"1345","author":"N\u00e8gre-Aminou","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib66","first-page":"680","article-title":"Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques: in\u00a0vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits","volume":"48","author":"Shiomi","year":"1998","journal-title":"Arzneim Forsh\/Drug Res"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib67","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.0000084638.14534.0A","article-title":"Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid","volume":"23","author":"Proctor","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib68","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.bbrc.2011.03.069","article-title":"Species differences of macrophage very low-density-lipoprotein (VLDL) receptor protein expression","volume":"407","author":"Takahashi","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2013.08.030_bib69","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013005066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013005066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T13:17:16Z","timestamp":1646486236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013005066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0021915013005066"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.08.030","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}